Racial differences and geographic variations in oral anticoagulation treatment among Medicare patients with non-valvular atrial fibrillation
Larry R. Jackson, Amiee Kang, Virginia Noxon, Nipun Atreja, Dionne M. Hines, Melissa Hagan, Jenny Jiang, Brett D. Atwater · 2024
Read Racial differences and geographic variations in oral anticoagulation treatment among Medicare patients with non-valvular atrial fibrillation by Larry R. Jackson, Amiee Kang, Virginia Noxon, Nipun Atreja, Dionne M. Hines, Melissa Hagan, Jenny Jiang, Brett D. Atwater (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11637370.txt.
Description
Larry Jackson and co-authors map racial and geographic gaps in blood thinner use for a common heart rhythm disorder. Their 2024 study uses Medicare claims from 2013 to 2016. Thinners cut stroke risk in atrial fibrillation, yet use varies by race and place in the United States.
The final set holds near 2.4 million patients with a high stroke risk score, split between Black and White patients. Black patients carry higher risk and bleeding scores on average. Yet their no-treatment rate tops the White rate by about nine points nationwide. County assignment lets the team chart how the gap shifts across regions. The study seeks the pattern behind underuse so fixes can target place and group together.
Catalog record
| CREATOR | Larry R. Jackson, Amiee Kang, Virginia Noxon, Nipun Atreja, Dionne M. Hines, Melissa Hagan, Jenny Jiang, Brett D. Atwater |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |